ARHGEF39 has been found to be associated with human hepatocellular carcinoma, gastric cancer and nonsmall cell lung cancer (Wang et al., 2012; Cook et al., 2014; Wang et al., 2018; Zhou et al., 2018). Here, ARHGEF39 is linked to gastric cancer.